Saturday, September 26, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchhumaninklebsiella pneumoniaeliver injurymitochondrial peptides

Humanin pretreatment limits liver injury in Klebsiella-infected mice

Serum humanin was higher in 20 patients with hypervirulent Klebsiella bloodstream infection and liver abscess than in 20 matched healthy controls.

PR
By Priya Raman · Science Reporter
Sep 9 20:00 ETSource: Pathogens (Basel, Switzerland)

The wire

  1. 01Mice given intraperitoneal humanin at 2.5 or 5 mg/kg/day for five days before hvKP challenge showed lower ALT, AST and PCT, reduced NF-kB activation and, at 5 mg/kg, longer survival.
  2. 02Humanin is tracked by readers as a mitochondria-derived longevity peptide; this is one of the few datasets linking it to infection-driven inflammation and macrophage signaling.
  3. 03The work is a mouse pretreatment model with a 20-patient observational comparison; the authors note humanin's molecular targets remain unknown.

From the source

Humanin Attenuates Inflammatory Liver Injury and NF-κB Activation During Systemic Hypervirulent Klebsiella pneumoniae Infection

Pathogens (Basel, Switzerland) · 2026 Sep 10 · Zhong Y, Haishaer D, Cai W et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →